(0.33%) 5 116.80 points
(0.33%) 38 367 points
(0.37%) 15 986 points
(-0.94%) $83.06
(5.36%) $2.03
(0.34%) $2 355.20
(0.52%) $27.68
(4.16%) $960.45
(-0.27%) $0.932
(-0.46%) $10.97
(-0.56%) $0.796
(1.66%) $93.40
@ $17.14
発行日: 14 2月 2024 @ 05:41
リターン: -49.53%
前回のシグナル: 2月 13 - 03:54
前回のシグナル:
リターン: 0.06 %
Live Chart Being Loaded With Signals
AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo...
Stats | |
---|---|
本日の出来高 | 67 184.00 |
平均出来高 | 236 190 |
時価総額 | 223.17M |
EPS | $0 ( 2024-02-22 ) |
次の収益日 | ( $-0.260 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -6.18 |
ATR14 | $0.0260 (0.30%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-28 | O'toole David D | Buy | 250 | Common Stock |
2024-02-28 | O'toole David D | Buy | 1 000 | Common Stock |
2024-01-03 | Shiroma Donna | Buy | 100 000 | Stock Options (Right to Buy) |
2023-11-30 | Shiroma Donna | Buy | 1 469 | Common Stock |
2024-01-03 | O'toole David D | Buy | 125 000 | Stock Options (Right to Buy) |
INSIDER POWER |
---|
72.68 |
Last 97 transactions |
Buy: 1 597 984 | Sell: 352 272 |
ボリューム 相関
Avita Therapeutics Inc 相関
10 最も負の相関 | |
---|---|
SVAC | -0.949 |
FRBK | -0.94 |
AROW | -0.937 |
BCBP | -0.93 |
BWB | -0.926 |
GSMG | -0.921 |
DSWL | -0.92 |
ESPR | -0.919 |
VGFC | -0.918 |
FVCB | -0.917 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Avita Therapeutics Inc 相関 - 通貨/商品
Avita Therapeutics Inc 財務諸表
Annual | 2022 |
収益: | $34.42M |
総利益: | $28.38M (82.45 %) |
EPS: | $-1.070 |
FY | 2022 |
収益: | $34.42M |
総利益: | $28.38M (82.45 %) |
EPS: | $-1.070 |
FY | 2021 |
収益: | $29.23M |
総利益: | $23.28M (79.65 %) |
EPS: | $-1.170 |
FY | 2020 |
収益: | $14.26M |
総利益: | $11.29M (79.16 %) |
EPS: | $-2.07 |
Financial Reports:
No articles found.
Avita Therapeutics Inc
AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and a research collaboration with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. was incorporated in 2000 and is based in Valencia, California.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。